assay. However, we found discrepancies between results of the PW71 methylation assay and previous results of DNA polymorphism or FISH in 17% of LB cell lines. In our study, some LB cell lines showed either hypermethylation or hypomethylation at the CfoI sites at the PW7 1 site.
We also found hypomethylation in CVS and one placental tissue using the PW71B probe. These results were consistent with previous reports where hypomethylation has been shown at PW7 1 in CVS,9"0 placenta, and several tumours'°although a consistent methylation pattern has been shown in a few AF samples.9"0 Appropriate SNRPN methylation patterns have recently been reported in several fetal tissues with the exception of fetal testes.'6 In our study, cultured cells from AF and CVS showed concordant results between the SNRPN methylation and DNA polymorphism analysis. Results of the SNRPN methylation assay were also consistent between AF, CVS, and fetal tissues. These results suggest that SNRPN methylation in either cultured AF cells or cultured CVS cells may accurately reflect the methylation status of the fetus.
Recently several familial PWS/AS families have been reported in which small deletions were identified at the region between the PW7 1 locus and the SNRPN gene which could not be detected using either commercially available FISH probes or DNA polymorphism analysis with current markers. These deletions are thought to encompass a putative imprinting centre" and affected subjects in these families show abnormal methylation patterns. Recurrence risk in these families is high (50%) for carriers of the imprinting mutation. For these cases, the SNRPN methylation analysis could provide a prenatal diagnosis option using AF samples or CVS.
Conclusion
The data presented here confirm that the SNRPN methylation assay is consistent with other molecular cytogenetic tests in all tissues examined. Our data verify the usefulness of the SNRPN methylation assay in diagnosis of PWS/AS using LB cell lines, cultured AF samples, and CVS, which can, for the first time, provide prenatal diagnosis for families with imprinting mutations.
